Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-006443

CEO bought 25,000 shares at $2.16 ($54,000)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-16 Purchase : show line 1 in the form +25,000 $2.16 $54,000 88,001 I
Open-market purchases · 25,000 sh · avg $2.16 · $54,000
Loading xslF345X03/wf-form4_164747330857843.xml…